Understanding European regulatory requirements for low-GWP propellant transition
By Catherine Eckford (European Pharmaceutical Review)
CSL to slash headcount by 15% and spinout its CSL Seqirus vaccines business
By Dominic Tyer (European Pharmaceutical Review)
Trump executive order targets US pharma supply chain resilience
By Dominic Tyer (European Pharmaceutical Review)
Sanofi accelerates towards its ‘factory of the future’ vision
By Dominic Tyer (European Pharmaceutical Review)
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
By Dominic Tyer (European Pharmaceutical Review)